Now live: Pro — the full 13F research suite for serious investorsSee pricing →
ABG Innovation Capital Partners III GP Ltd

Q2 2024 · 13F-HR

ABG Innovation Capital Partners III GP Ltdholdings as filed

Filed 2024-08-14 · accession 0000950123-24-008425

$859,505
Reported value
3
Positions
2024-06-30
Period end
View analyzed profile →PRO

Holdings as filed

CUSIPTickerIssuerValue% port.SharesClassVoting
14843C105CSTLCASTLE BIOSCIENCES INC$799,98293.1%36,747CommonSOLE
00032Q104WHWKAADI BIOSCIENCES INC$38,9324.53%26,666CommonSOLE
87166L209SYBXSYNLOGIC INC$20,5912.40%13,727CommonSOLE

Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.